Compound ID | 31
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Staphylococcus aureus |
| Institute where first reported: | State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | http://aac.asm.org/content/58/9/5342.full |